By Will Feuer


Pfizer Inc. is recalling about 4.2 million units of Nurtec ODT prescription drugs because the packaging isn't child resistant.

The packaging of the more than 4 million units of the prescription migraine medication failed to meet the requirements of the Poison Prevention Packaging Act, the U.S. Consumer Product Safety Commission said.

The recall applies to 75 milligram Nurtec ODT orally disintegrating tablets that are sold in cartons containing one blister card of 8 tablets. According to the CPSC, the tablets are in a non-child resistant blister card.

The recall applies to all units with an expiration date through June 2026, the CPSC said.


Write to Will Feuer at


(END) Dow Jones Newswires

March 16, 2023 10:02 ET (14:02 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
過去 株価チャート
から 5 2023 まで 6 2023 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 6 2022 まで 6 2023 Pfizerのチャートをもっと見るにはこちらをクリック